Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist

Psychopharmacology

Volumn 232, Issue 12, 2015, Pages 2181-2189

  Ago, Yukio ^a,b   Condro, Michael C ^a   Tan, Yossan Var ^c   Ghiani, Cristina A ^a   Colwell, Christopher S ^d   Cushman, Jesse D ^d   Fanselow, Michael S ^a,d   Hashimoto, Hitoshi ^b   Waschek, James A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF ROUEN   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Mouse; Prepulse inhibition; PSD 95; Schizophrenia; Synaptophysin; VPAC2 receptor (VIPR2)

Indexed keywords

POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPTOPHYSIN; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2; CYCLOPEPTIDE; DLGH4 PROTEIN, MOUSE; GUANYLATE KINASE; MEMBRANE PROTEIN; NERVE PROTEIN; RO 25-1553; VASOACTIVE INTESTINAL POLYPEPTIDE; VIPR2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MATURATION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; POSTNATAL DEVELOPMENT; PREFRONTAL CORTEX; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNAPTOGENESIS; WESTERN BLOTTING; AGONISTS; ANIMAL; C57BL MOUSE; DRUG EFFECTS; FEAR; HUMAN RELATION; METABOLISM; MOTOR ACTIVITY; NEWBORN; PREGNANCY; STARTLE REFLEX; SYNAPSE;

ANIMALS; ANIMALS, NEWBORN; FEAR; FEMALE; GUANYLATE KINASE; INTERPERSONAL RELATIONS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PEPTIDES, CYCLIC; PREGNANCY; PREPULSE INHIBITION; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE, TYPE II; REFLEX, STARTLE; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTOPHYSIN; VASOACTIVE INTESTINAL PEPTIDE;

EID: 84929340167     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3848-z     Document Type: Article

References (57)

1. Allais A, Burel D, Isaac ER, Gray SL, Basille M, Ravni A, Sherwood NM, Vaudry H, Gonzalez BJ (2007) Altered cerebellar development in mice lacking pituitary adenylate cyclase-activating polypeptide. Eur J Neurosci 25:2604-2618
2. Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, McCarren HS, Siegel SJ (2010) Mouse behavioral endophenotypes for schizophrenia. Brain Res Bull 83:147-161
3. Braff DL, Swerdlow NR, Geyer MA (1999) Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 156:596-602
4. Charitidi K, Meltser I, Canlon B (2012) Estradiol treatment and hormonal fluctuations during the estrous cycle modulate the expression of estrogen receptors in the auditory system and the prepulse inhibition of acoustic startle response. Endocrinology 153:4412-4421
5. Council NR (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, DC
6. Eastwood SL, Cairns NJ, Harrison PJ (2000) Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex. Br J Psychiatry 176:236-242
7. Falluel-Morel A, Chafai M, Vaudry D, Basille M, Cazillis M, Aubert N, Louiset E, de Jouffrey S, Le Bigot JF, Fournier A, Gressens P, Rostène W, Vaudry H, Gonzalez BJ (2007) The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells. J Neuroendocrinol 19:321-327
8. Faludi G, Mirnics K (2011) Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 29:305-309
9. Feyder M, Karlsson RM, Mathur P, Lyman M, Bock R, Momenan R, Munasinghe J, Scattoni ML, Ihne J, Camp M, Graybeal C, Strathdee D, Begg A, Alvarez VA, Kirsch P, Rietschel M, Cichon S, Walter H, Meyer-Lindenberg A, Grant SG, Holmes A (2010) Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Am J Psychiatry 167:1508-1517
10. Gale GD, Yazdi RD, Khan AH, Lusis AJ, Davis RC, Smith DJ (2009) A genome-wide panel of congenic mice reveals widespread epistasis of behavior quantitative trait loci. Mol Psychiatry 14:631-645
11. Ghiani C, Gallo V (2001) Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells. J Neurosci 21:1274-1282
12. Girard BM, Keller ET, Schutz KC, May V, Braas KM (2004) Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons. Regul Pept 123:107-116
13. Glantz LA, Lewis DA (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 54:943-952
14. Gourlet P, Vertongen P, Vandermeers A, Vandermeers-Piret MC, Rathe J, De Neef P, Waelbroeck M, Robberecht P (1997) The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass. Peptides 18:403-408
15. Hanks AN, Dlugolenski K, Hughes ZA, Seymour PA, Majchrzak MJ (2013) Pharmacological disruption of mouse social approach behavior: relevance to negative symptoms of schizophrenia. Behav Brain Res 252:405-414
16. Harmar AJ (2003) An essential role for peptidergic signalling in the control of circadian rhythms in the suprachiasmatic nuclei. J Neuroendocrinol 15:335-338
17. Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JR, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, Wank SA, Waschek JA (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50:265-270
18. Harmar AJ, Marston HM, Shen S, Spratt C, West KM, Sheward WJ, Morrison CF, Dorin JR, Piggins HD, Reubi JC, Kelly JS, Maywood ES, Hastings MH (2002) The VPAC2 receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 109:497-508
19. Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, Vaudry D, Vaudry H, Waschek JA, Said SI (2012) Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol 166:4-17
20. Hattori T, Baba K, Matsuzaki S, Honda A, Miyoshi K, Inoue K, Taniguchi M, Hashimoto H, Shintani N, Baba A, Shimizu S, Yukioka F, Kumamoto N, Yamaguchi A, Tohyama M, Katayama T (2007) A novel DISC1-interacting partner DISC1-Binding Zinc-finger protein: implication in the modulation of DISC1-dependent neurite outgrowth. Mol Psychiatry 12:398-407
21. Hermes G, Li N, Duman C, Duman R (2011) Post-weaning chronic social isolation produces profound behavioral dysregulation with decreases in prefrontal cortex synaptic-associated protein expression in female rats. Physiol Behav 104:354-359
22. Holt DJ, Lebron-Milad K, Milad MR, Rauch SL, Pitman RK, Orr SP, Cassidy BS, Walsh JP, Goff DC (2009) Extinction memory is impaired in schizophrenia. Biol Psychiatry 65:455-463
23. Holt DJ, Coombs G, Zeidan MA, Goff DC, Milad MR (2012) Failure of neural responses to safety cues in schizophrenia. Arch Gen Psychiatry 69:893-903
24. Insel TR (2010) Rethinking schizophrenia. Nature 468:187-193
25. Itri J, Colwell CS (2003) Regulation of inhibitory synaptic transmission by vasoactive intestinal peptide (VIP) in the mouse suprachiasmatic nucleus. J Neurophysiol 90:1589-1597
26. Jacobs NS, Cushman JD, Fanselow MS (2010) The accurate measurement of fear memory in Pavlovian conditioning: resolving the baseline issue. J Neurosci Methods 190:235-239
27. Karson CN, Mrak RE, Schluterman KO, Sturner WQ, Sheng JG, Griffin WS (1999) Alterations in synaptic proteins and their encoding mRNAs in prefrontal cortex in schizophrenia: a possible neurochemical basis for 'hypofrontality'. Mol Psychiatry 4:39-45
28. Kristiansen LV, Beneyto M, Haroutunian V, Meador-Woodruff JH (2006) Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry 11:737-747
29. Levinson DF, Duan J, Oh S, Wang K, Sanders AR, Shi J, Zhang N, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Kendler KS, Freedman R, Dudbridge F, Pe'er I, Hakonarson H, Bergen SE, Fanous AH, Holmans PA, Gejman PV (2011) Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 168:302-316
30. Matsuyama S, Matsumoto A, Hashimoto H, Shintani N, Baba A (2003) Impaired long-term potentiation in vivo in the dentate gyrus of pituitary adenylate cyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice. Neuroreport 14:2095-2098
31. McGlashan TH, Hoffman RE (2000) Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57:637-648
32. Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, Young NB, Barbaro RP, Piven J, Magnuson TR, Crawley JN (2004) Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav 3:303-314
33. Nakamachi T, Farkas J, Watanabe J, Ohtaki H, Dohi K, Arata S, Shioda S (2011) Role of PACAP in neural stem/progenitor cell and astrocyte: from neural development to neural repair. Curr Pharm Des 17:973-984
34. Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Phillips TM (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 49:597-606
35. Niewiadomski P, Zhujiang A, Youssef M, Waschek JA (2013) Interaction of PACAP with sonic hedgehog reveals complex regulation of the hedgehog pathway by PKA. Cell Signal 25:2222-2230
36. Ohnuma T, Kato H, Arai H, Faull RL, McKenna PJ, Emson PC (2000) Gene expression of PSD95 in prefrontal cortex and hippocampus in schizophrenia. Neuroreport 11:3133-3137
37. O'Kusky JR, Ye P, D'Ercole AJ (2000) Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J Neurosci 20:8435-8442
38. Otto C, Kovalchuk Y, Wolfer DP, Gass P, Martin M, Zuschratter W, Gröne HJ, Kellendonk C, Tronche F, Maldonado R, Lipp HP, Konnerth A, Schütz G (2001) Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J Neurosci 21:5520-5527
39. Pakhotin P, Harmar AJ, Verkhratsky A, Piggins H (2006) VIP receptors control excitability of suprachiasmatic nuclei neurones. Pflugers Arch 452:7-15
40. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, Giustetto M, Ferreira TA, Guiducci E, Dumas L, Ragozzino D, Gross CT (2011) Synaptic pruning by microglia is necessary for normal brain development. Science 333:1456-1458
41. Pascual R, Zamora-León SP, Valero-Cabré A (2006) Effects of postweaning social isolation and re-socialization on the expression of vasoactive intestinal peptide (VIP) and dendritic development in the medial prefrontal cortex of the rat. Acta Neurobiol Exp (Wars) 66:7-14
42. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3-33
43. Regldi D, Kiss P, Tamás A, Lengvári I (2003) The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats. Behav Brain Res 140:131-139
44. Romero E, Guaza C, Castellano B, Borrell J (2010) Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia. Mol Psychiatry 15:372-383
45. Sebat J, Levy DL, McCarthy SE (2009) Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet 25:528-535
46. Silverman JL, Yang M, Lord C, Crawley JN (2010) Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 11:490-502
47. Suh J, Lu N, Nicot A, Tatsuno I, DiCicco-Bloom E (2001) PACAP is an anti-mitogenic signal in developing cerebral cortex. Nat Neurosci 4:123-124
48. Swerdlow NR, Light GA, Cadenhead KS, Sprock J, Hsieh MH, Braff DL (2006) Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry 63:1325-1335
49. Vacic V, McCarthy S, Malhotra D, Murray F, Chou HH, Peoples A, Makarov V, Yoon S, Bhandari A, Corominas R, Iakoucheva LM, Krastoshevsky O, Krause V, Larach-Walters V, Welsh DK, Craig D, Kelsoe JR, Gershon ES, Leal SM, Dell Aquila M, Morris DW, Gill M, Corvin A, Insel PA, McClellan J, King MC, Karayiorgou M, Levy DL, DeLisi LE, Sebat J (2011) Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia. Nature 471:499-503
50. Walf AA, Koonce C, Manley K, Frye CA (2009) Proestrous compared to diestrous wildtype, but not estrogen receptor beta knockout, mice have better performance in the spontaneous alternation and object recognition tasks and reduced anxiety-like behavior in the elevated plus and mirror maze. Behav Brain Res 196:254-260
51. Waschek JA (1996) VIP and PACAP receptor-mediated actions on cell proliferation and survival. Ann N Y Acad Sci 805:290-300
52. Waschek JA, Ellison J, Bravo DT, Handley V (1996) Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes. J Neurochem 66:1762-1765
53. Yamada K, Matsuzaki S, Hattori T, Kuwahara R, Taniguchi M, Hashimoto H, Shintani N, Baba A, Kumamoto N, Yamada K, Yoshikawa T, Katayama T, Tohyama M (2010) Increased stathmin1 expression in the dentate gyrus of mice causes abnormal axonal arborizations. PLoS One 5:e8596
54. Ye P, Li L, Richards RG, DiAugustine RP, D'Ercole AJ (2002) Myelination is altered in insulin-like growth factor-I null mutant mice. J Neurosci 22:6041-6051
55. Yuan J, Jin C, Sha W, Zhou Z, Zhang F, Wang M, Wang J, Li J, Feng X, Yu S, Wang J (2014) A competitive PCR assay confirms the association of a copy number variation in the VIPR2 gene with schizophrenia in Han Chinese. Schizophr Res 156:66-70
56. Zelikowsky M, Hast TA, Bennett RZ, Merjanian M, Nocera NA, Ponnusamy R, Fanselow MS (2013) Cholinergic blockade frees fear extinction from its contextual dependency. Biol Psychiatry 73:345-352
57. Zupan V, Nehlig A, Evrard P, Gressens P (2000) Prenatal blockade of vasoactive intestinal peptide alters cell death and synaptic equipment in the murine neocortex. Pediatr Res 47:53-63